PureTech Health (PRTC) EPS (Weighted Average and Diluted) (2024)
PureTech Health (PRTC) reported EPS (Weighted Average and Diluted) of -$278486.7 for Q2 2024.
PureTech Health (PRTC) EPS (Weighted Average and Diluted) (2024) Analysis & Trends
PureTech Health (PRTC) has 1 years of EPS (Weighted Average and Diluted) data on file, last reported at -$278486.7 in Q2 2024.
- EPS (Weighted Average and Diluted) for Q2 2024 came in at -$278486.7, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was -$278486.7 (changed N/A YoY), and the FY2025 annual result was -$0.46, down 319.05% from the prior year.
- EPS (Weighted Average and Diluted) steadied at -$278486.7 in Q2 2024 per PRTC's latest filing.
- Over five years, EPS (Weighted Average and Diluted) peaked at -$278486.7 in Q2 2024 and troughed at -$278486.7 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -278,486.67 |